Clinical Effectiveness and Pharmacokinetics of Dalbavancin in Treatment-Experienced Patients with Skin, Osteoarticular, or Vascular Infections.

Pharmaceutics · 2022 · PMC9501058 · PMID 36145630

Europe PMC DOI

hedged sentence

0.0530

closest p · 1.1× alpha

0.0530

boldest claim

The sentences

trend toward significancep = 0.053so close (0.05 < p ≤ 0.1)

Concurrently, the highest efficacy was highlighted in group 1 , especially when compared with the other groups, with a solid trend toward significance ( p = 0.053, cured vs. not cured).

also in 304 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.